Té  Vuong

Associate Professor

Oncology

Address:
Division of Radiation Oncology
Segal Cancer Centre
Jewish General Hospital
3755 Côte Ste. Catherine Rd.
Montreal, QC H3T 1E2

Telephone: 514-340-8288
E-mail: tvuong@jgh.mcgill.ca

Education: M.D., Université de Montréal

Clinical Focus: Rectal Cancer , Esophageal Cancer, Anal Canal Cancer, Radiation Technology, Brachytherapy

Research Focus: Radiation Therapy; Targeted Therapy; Clinical applications of nanorobotic technology; Intra operative radiation therapy; Optimize organ preservation (rectal cancer)


Recent Presentations:

Vuong, T. "Les bactéries à l’assaut du cancer" - Découverte - Radio-Canada. November 20, 2016

Vuong, T. Évolution de la technologie de l’imagerie et contribution dans l’approche des traitements en Radio-oncologie. Hôpital Pierre-Boucher, CISSS de la Montérégie-Est. November 4, 2016

Vuong, T. L’approche non chirurgicale dans le cancer rectal. Hôpital Pierre-Boucher, CISSS de la Montérégie-Est. November 4, 2016

Vuong, T. Approches non chirurgicales pour les patients avec cancer: Risques et bénéfices. Centre de cancérologie du CISSS de Laval; hôpital Cité-de-la-santé. October 31, 2016

Evans J, Bhoday J, Sizer B, Tekkis P, Swift R, Perez R, Tait D, Vuong, T, & al. Brown G. Results of a prospective randomised control 6 vs 12 trial: Is greater tumour downstaging observed on post treatment MRI if surgery is delayed to 12-weeks versus 6-weeks after completion of neoadjuvant chemoradiotherapy? ESMO Congress Copenhagen. October 9, 2016. Oral presentation. abstract #4520.

Vuong, T. Case presentation on “When to propose organ preservation after major response after RTCHEM or 5x5 delay surgery” in the session “Organ preservation in on-going clinical practice”. 4th World Rectal Conference: the organ preservation challenge. Rome, Italy. October 7, 2016

Vuong, T. “Bowel Function as per Radiation Modality” in the session “On-going research on W&W and TEM strategies”. 4th World Rectal Conference: the organ preservation challenge. Rome, Italy. October 7, 2016

Vuong, T. Case presentation on “Unfit cases for surgery or refused surgery with early cancer” in the session “Patient selection”. 4th World Rectal Conference: the organ preservation challenge. Rome, Italy. October 6, 2016

Vuong, T. Role of High dose rate brachytherapy for oesophageal cancer. World Congress of Brachytherapy. San Francisco, USA. June 27-29, 2016

Vuong, T. Image guided (CT/MR) High dose rate brachytherapy for rectal cancer (pre-op and definitive treatment). World Congress of Brachytherapy. San Francisco, USA. June 27-29, 2016

Nout R, Vuong, T, Devic S, Bekerat H. Is Daily CT-based Adaptive Endorectal Brachytherapy of Benefit Compared to using a Single Treatment Plan for Preoperative Treatment of Locally Advanced Rectal Cancer? World Congress of Brachytherapy. San Francisco, California. June 27-29, 2016. Oral presentation, abstract #408.

Vuong, T. Are we ready yet for a randomized study for non surgical option for patients with operable rectal cancer? CHUQ Colo-rectal Research Meeting, Quebec, Canada. June 6, 2016

Vuong, T. Impact of timing of chemotherapy in the treatment of patients with operable rectal cancer: a randomized phase II multicentric study. Montreal colo-rectal cancer Research meeting Investigators Meeting, Montreal, Quebec, Canada. May 30, 2016

Vuong, T. Rectal preservation for patients with rectal cancer. Montreal Colo-rectal cancer Research Meeting, Montreal, Quebec, Canada. May 30, 2016

Vuong, T, Desjardins F, Pelsser V, Niazi T, Robillard A, Leventhal M. Patterns of relapse in rectal cancer patients following pre-operative high dose rate brachytherapy. ESTRO 35. Turin, Italy. April 30, 2016. Oral presentation, abstract E35-0985.

Vuong, T. Radiothérapie intra-opératoire pour le cancer du sein: un modèle adapté à la réalité d’aujourd’hui. Centre intégré de santé et de services sociaux de la Montérégie Est. April 5, 2016


Recent Publications:

Please click here for Dr. Té Vuong’s complete publication list.